HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA reform bill

This article was originally published in The Rose Sheet

Executive Summary

FDA reform bill: House Commerce Committee may release a draft of FDA reform legislation the first week in July with Commerce Committee Chairman Thomas Bliley (R-VA) and Health Subcommittee Chairman Michael Bilirakis (R-FL) as likely sponsors for a Republican bill. The development of a final proposal by Republicans is made easier by the June 6 introduction of Rep. Wyden's (D-OR) minority alternative (HR 1742), which sets the foundation for GOP options and identifies several common themes: more use of expert panels, fewer export restrictions on products under development in the U.S. and a review of FDA promotion controls...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS001728

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel